[HTML] frontiersin.org

[HTML][HTML] Targeting cellular and tissue HIV reservoirs with toll-like receptor agonists

AB Macedo, CL Novis, A Bosque - Frontiers in immunology, 2019 - frontiersin.org
The elimination of both cellular and tissue latent reservoirs is a challenge toward a
successful HIV cure.“Shock and Kill” are among the therapeutic strategies that have been …
被引用次数：68 相关文章
[HTML] nih.gov

[HTML][HTML] Targeting Cellular and Tissue HIV Reservoirs With Toll-Like Receptor Agonists

AB Macedo, CL Novis, A Bosque - Frontiers in Immunology, 2019 - ncbi.nlm.nih.gov
The elimination of both cellular and tissue latent reservoirs is a challenge toward a
successful HIV cure.“Shock and Kill” are among the therapeutic strategies that have been …

[引用][C] Targeting Cellular and Tissue HIV Reservoirs With Toll-Like Receptor Agonists.

AB Macedo, CL Novis… - Frontiers in …, 2019 - hsrc.himmelfarb.gwu.edu
"Targeting Cellular and Tissue HIV Reservoirs With Toll-Like Receptor A" by Amanda B.
Macedo, Camille L Novis et al. Home Search Browse Collections My Account About DC Network …

Targeting Cellular and Tissue HIV Reservoirs With Toll-Like Receptor Agonists.

AB Macedo, CL Novis, A Bosque - Frontiers in Immunology, 2019 - europepmc.org
The elimination of both cellular and tissue latent reservoirs is a challenge toward a
successful HIV cure.“Shock and Kill” are among the therapeutic strategies that have been …

Targeting Cellular and Tissue HIV Reservoirs With Toll-Like Receptor Agonists

AB Macedo, CL Novis… - Frontiers in …, 2019 - pubmed.ncbi.nlm.nih.gov
The elimination of both cellular and tissue latent reservoirs is a challenge toward a
successful HIV cure." Shock and Kill" are among the therapeutic strategies that have been …